Leber's Congenital Amaurosis: Clinical Trials

1 trial for Leber's Congenital Amaurosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Leber's Congenital Amaurosis: new trials by email Literature Review of Leber's Congenital Amaurosis trials Research Report on Leber's Congenital Amaurosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate QR-110 in Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
QR-110 - Leber's Congenital Amaurosis
Phase 1 / Phase 2CompletedLaboratoires Thea112017-10-162024-10-15

Narrower conditions

Meckel Syndrome, Type 4 (1)  ·  Optic Atrophy, Hereditary, Leber (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Cranial Nerve Diseases (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Metabolic Diseases (1)  ·  Mitochondrial Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Optic Atrophies, Hereditary (1)  ·  Optic Atrophy (1)  ·  Optic Nerve Diseases (1)

Sponsors

Laboratoires Thea (1)

Countries

Belgium (1)  ·  United States (1)

Results publications

PMID 30559420, PMID 31215818, PMID 33795869, PMID 35379979

NIH funding

2017 (1)